当期変動額合計、Transfer From Other Components Of Equity To Retained EarningsSSIFRS、出資金売却益他1件
- 【期間】
年度 | 当期変動額合計 | Transfer From Other Components Of Equity To Retained EarningsSSIFRS | 出資金売却益 | 研究開発費 - 医療関連事業 |
---|
2020/03 | - | | - | | - | | 7.28億 | |
2021/03 | - | | - | | - | | 5.34億 | -26.6% |
2022/03 | - | | - | | - | | 12.9億 | +141.6% |